Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Common stock
-
Shares outstanding
-
47,144,064
-
Total 13F shares
-
12,574,186
-
Share change
-
-111,243
-
Total reported value
-
$213,400,829
-
Price per share
-
$16.97
-
Number of holders
-
51
-
Value change
-
-$7,136,755
-
Number of buys
-
29
-
Number of sells
-
16
Institutional Holders of Whitehawk Therapeutics, Inc. - Common stock (WHWK) as of Q1 2022
As of 31 Mar 2022,
Whitehawk Therapeutics, Inc. - Common stock (WHWK) was held by
51 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,574,186 shares.
The largest 10 holders included
Avoro Capital Advisors LLC, VR Adviser, LLC, ACUTA CAPITAL PARTNERS, LLC, BVF INC/IL, Vivo Capital, LLC, RTW INVESTMENTS, LP, VANGUARD GROUP INC, STATE STREET CORP, Decheng Capital Management III (Cayman), LLC, and PRICE T ROWE ASSOCIATES INC /MD/.
This page lists
51
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.